Development and Manufacturing Services for New Biologics
Mammalian
With a solid foundation in analytics combined with our best-in-class cell line development (CLD) platform, KBI provides vertically integrated services for First in Human (FIH) programs from CLD through to commercial manufacturing.
More molecules are manufactured using an E. Coli expression system than ever before thanks to reimagined platforms, efficiency gains, and broader-based applicability. KBI is raising the bar on microbial expression and manufacturing, using an early optimization workflow to ensure manufacturing success.
Our extensive process and analytical development capabilities cover all stages, supporting early-stage development through small-scale protein production to fully-integrated, comprehensive process optimization leading to GMP manufacturing.
